As a tumor vaccine, eNVs‐FAP, which suppresses tumor growth by inducing a strong and specific CTL immune response directed against tumor cells and FAPCAF, as well as reprogramming immunosuppressive TMEs in models of colon, melanoma, lung, and breast cancer.366. The gene discussed is FAP; the disease is neoplasm.